S&P Healthcare Services SPDR (XHS)

Although CVS Health has underperformed its industry peers over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Molina Healthcare has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.

Wells Fargo analyst Stephen Baxter revised down the firm’s rating to ‘Equal Weight’ from ‘Overweight’ while Raymond James expects a reduction in the “Affordable Care Act exchange population...

HCA Healthcare has underperformed the broader market this year, but analysts remain optimistic about the stock's prospects.

Henry Schein has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Despite Humana underperforming the broader market over the past year, Wall Street analysts remain moderately bullish on the stock’s prospects.

While DaVita has outperformed the broader market over the past year, analysts on Wall Street are exercising caution regarding its future prospects.

Centene has underperformed the broader market over the past year and analysts remain cautiously bullish on the stock’s prospects.

DaVita is all set to release its third-quarter earnings this month, and analysts expect a single-digit profit dip.

Henry Schein outperformed its industry peers recently, and Wall Street analysts remain moderately optimistic about the stock’s prospects.